Puma Biotechnology, Inc. (PBYI)
5.69
-1.91
(-25.13%)
USD |
NASDAQ |
Feb 27, 16:00
5.69
0.00 (0.00%)
After-Hours: 16:16
Puma Biotechnology Research and Development Expense (Quarterly) : 15.91M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Nephros, Inc. | 0.338M |
| Pfizer Inc. | 3.206B |
| Rigel Pharmaceuticals, Inc. | 7.353M |
| CorMedix, Inc. | 5.098M |
| AbbVie, Inc. | 2.579B |